Helicobacter pylori serology in autoimmune diseases – fact or fiction? (original) (raw)

Conflict of interest statement

Authors’ conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

References

1. Shoenfeld Y, Selmi C, Zimlichman E, Gershwin ME. The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 2008;31:325–30.10.1016/j.jaut.2008.08.004 Search in Google Scholar

2. Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M, Amital H, Levy Y, et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases – 2008. Isr Med Assoc J 2008;10:8–12.Search in Google Scholar

3. Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y. Infections and autoimmunity – friends or foes? Trends Immunol 2009;30:409–14.10.1016/j.it.2009.05.005 Search in Google Scholar

4. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347:911–20.10.1056/NEJMra020100 Search in Google Scholar

5. Fae KC, da Silva DD, Oshiro SE, Tanaka AC, Pomerantzeff PM, Douay C, et al. Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J Immunol 2006;176:5662–70.10.4049/jimmunol.176.9.5662 Search in Google Scholar

6. Getts MT, Miller SD. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: triggering of autoimmune diseases by infections. Clin Exp Immunol 2010;160:15–21.10.1111/j.1365-2249.2010.04132.x Search in Google Scholar

7. Goodwin CS, Worsley BW. Microbiology of Helicobacter pylori. Gastroenterol Clin North Am 1993;22:5–19.10.1016/S0889-8553(21)00260-0 Search in Google Scholar

8. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175–86.10.1056/NEJMra020542 Search in Google Scholar PubMed

9. Hasni S, Ippolito A, Illei GG. Helicobacter pylori and autoimmune diseases. Oral Dis 2011;17:621–7.10.1111/j.1601-0825.2011.01796.x Search in Google Scholar PubMed PubMed Central

10. Amedei A, Bergman MP, Appelmelk BJ, Azzurri A, Benagiano M, Tamburini C, et al. Molecular mimicry between Helicobacter pylori antigens and H+, K+-adenosine triphosphatase in human gastric autoimmunity. J Exp Med 2003;198:1147–56.10.1084/jem.20030530 Search in Google Scholar PubMed PubMed Central

11. Yamanishi S, Iizumi T, Watanabe E, Shimizu M, Kamiya S, Nagata K, et al. Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect Immun 2006;74:248–56.10.1128/IAI.74.1.248-256.2006 Search in Google Scholar PubMed PubMed Central

12. Amital H, Govoni M, Maya R, Meroni PL, Ori B, Shoenfeld Y, et al. Role of infectious agents in systemic rheumatic diseases. Clin Exp Rheumatol 2008;26(1 Suppl 48):S27–32.Search in Google Scholar

13. Chen Y, Blaser MJ. Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med 2007;167: 821–7.10.1001/archinte.167.8.821 Search in Google Scholar PubMed

14. Emilia G, Luppi M, Zucchini P, Morselli M, Potenza L, Forghieri F, et al. Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles. Blood 2007;110:3833–41.10.1182/blood-2006-12-063222 Search in Google Scholar PubMed

15. Franchini M, Veneri D. Helicobacter pylori-associated immune thrombocytopenia. Platelets 2006;17:71–7.10.1080/09537100500438057 Search in Google Scholar PubMed

16. Shoenfeld Y_,_ Cervera R, Gershwin ME, editors. Diagnostic criteria in autoimmune diseases. Totowa: Humana Press, 2008.10.1007/978-1-60327-285-8 Search in Google Scholar

17. Barzilai O, Sherer Y, Ram M, Izhaky D, Anaya JM, Shoenfeld Y. Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann N Y Acad Sci 2007;1108:567–77.10.1196/annals.1422.059 Search in Google Scholar PubMed

18. Lidar M, Langevitz P, Barzilai O, Ram M, Porat-Katz BS, Bizzaro N, et al. Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role. Ann N Y Acad Sci 2009;1173:640–8.10.1111/j.1749-6632.2009.04673.x Search in Google Scholar PubMed

19. Amieva MR, El-Omar EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 2008;134:306–23.10.1053/j.gastro.2007.11.009 Search in Google Scholar PubMed

20. Rain JC, Selig L, De Reuse H, Battaglia V, Reverdy C, Simon S, et al. The protein-protein interaction map of Helicobacter pylori. Nature 2001;409:211–5.10.1038/35051615 Search in Google Scholar PubMed

21. Weeks DL, Eskandari S, Scott DR, Sachs G. A H+-gated urea channel: the link between Helicobacter pylori urease and gastric colonization. Science 2000;287:482–5.10.1126/science.287.5452.482 Search in Google Scholar PubMed

22. Fan X, Gunasena H, Cheng Z, Espejo R, Crowe SE, Ernst PB, et al. Helicobacter pylori urease binds to class II MHC on gastric epithelial cells and induces their apoptosis. J Immunol 2000;165:1918–24.10.4049/jimmunol.165.4.1918 Search in Google Scholar PubMed

23. Nilius M, Malfertheiner P. Helicobacter pylori enzymes. Aliment Pharmacol Ther 1996;10(Suppl 1):65–71.10.1046/j.1365-2036.1996.22164007.x Search in Google Scholar

24. Portal-Celhay C, Perez-Perez GI. Immune responses to Helicobacter pylori colonization: mechanisms and clinical outcomes. Clin Sci (Lond) 2006;110:305–14.10.1042/CS20050232 Search in Google Scholar

25. Robinson K, Kenefeck R, Pidgeon EL, Shakib S, Patel S, Polson RJ, et al. Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses. Gut 2008;57:1375–85.10.1136/gut.2007.137539 Search in Google Scholar

26. Fan XG, Chua A, Fan XJ, Keeling PW. Increased gastric production of interleukin-8 and tumour necrosis factor in patients with Helicobacter pylori infection. J Clin Pathol 1995;48:133–6.10.1136/jcp.48.2.133 Search in Google Scholar

27. Tombola F, Morbiato L, Del Giudice G, Rappuoli R, Zoratti M, Papini E. The Helicobacter pylori VacA toxin is a urea permease that promotes urea diffusion across epithelia. J Clin Invest 2001;108:929–37.10.1172/JCI13045 Search in Google Scholar

28. Lu H, Yamaoka Y, Graham DY. Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol 2005;21:653–9.10.1097/01.mog.0000181711.04529.d5 Search in Google Scholar

29. Van Doorn LJ, Figueiredo C, Megraud F, Pena S, Midolo P, Queiroz DM, et al. Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology 1999;116:823–30.10.1016/S0016-5085(99)70065-X Search in Google Scholar

30. Ersoy O, Ersoy R, Yayar O, Demirci H, Tatlican S. H pylori infection in patients with Behcet’s disease. World J Gastroenterol 2007;13:2983–5.10.3748/wjg.v13.i21.2983 Search in Google Scholar PubMed PubMed Central

31. Machet L, Vaillant L, Machet MC, Buchler M, Lorette G. Schonlein-Henoch purpura associated with gastric Helicobacter pylori infection. Dermatology 1997;194:86.10.1159/000246068 Search in Google Scholar PubMed

32. Kalabay L, Fekete B, Czirjak L, Horvath L, Daha MR, Veres A, et al. Helicobacter pylori infection in connective tissue disorders is associated with high levels of antibodies to mycobacterial hsp65 but not to human hsp60. Helicobacter 2002;7:250–6.10.1046/j.1523-5378.2002.00092.x Search in Google Scholar PubMed

33. Aragona P, Magazzu G, Macchia G, Bartolone S, Di Pasquale G, Vitali C, et al. Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjogren’s syndrome. J Rheumatol 1999;26:1306–11.Search in Google Scholar

34. Grossman C, Dovrish Z, Shoenfeld Y, Amital H. Do infections facilitate the emergence of systemic sclerosis? Autoimmun Rev 2011;10:244–7.10.1016/j.autrev.2010.09.010 Search in Google Scholar PubMed

35. Radic M, Martinovic Kaliterna D, Bonacin D, Morovic Vergles J, Radic J. Correlation between Helicobacter pylori infection and systemic sclerosis activity. Rheumatology (Oxford) 2010;49:1784–5.10.1093/rheumatology/keq137 Search in Google Scholar PubMed

36. Durazzo M, Rosina F, Premoli A, Morello E, Fagoonee S, Innarella R, et al. Lack of association between seroprevalence of Helicobacter pylori infection and primary biliary cirrhosis. World J Gastroenterol 2004;10:3179–81.10.3748/wjg.v10.i21.3179 Search in Google Scholar PubMed PubMed Central

37. Bassi V, Santinelli C, Iengo A, Romano C. Identification of a correlation between Helicobacter pylori infection and Graves’ disease. Helicobacter 2010;15:558–62.10.1111/j.1523-5378.2010.00802.x Search in Google Scholar PubMed

38. Sagi L, Baum S, Agmon-Levin N, Sherer Y, Katz BS, Barzilai O, et al. Autoimmune bullous diseases the spectrum of infectious agent antibodies and review of the literature. Autoimmun Rev 2011;10:527–35.10.1016/j.autrev.2011.04.003 Search in Google Scholar PubMed

39. El Miedany YM, Baddour M, Ahmed I, Fahmy H. Sjogren’s syndrome: concomitant H. pylori infection and possible correlation with clinical parameters. Joint Bone Spine 2005;72:135–41.10.1016/j.jbspin.2004.04.005 Search in Google Scholar PubMed

40. Theander E, Nilsson I, Manthorpe R, Jacobsson LT, Wadstrom T. Seroprevalence of Helicobacter pylori in primary Sjogren’s syndrome. Clin Exp Rheumatol 2001;19:633–8.Search in Google Scholar

41. Strachan DP. Hay fever, hygiene, and household size. Br Med J 1989;299:1259–60.10.1136/bmj.299.6710.1259 Search in Google Scholar PubMed PubMed Central

42. Zaccone P, Fehervari Z, Jones FM, Sidobre S, Kronenberg M, Dunne DW, et al. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol 2003;33:1439–49.10.1002/eji.200323910 Search in Google Scholar PubMed

43. Tracy S, Drescher KM, Chapman NM, Kim KS, Carson SD, Pirruccello S, et al. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J Virol 2002;76:12097–111.10.1128/JVI.76.23.12097-12111.2002 Search in Google Scholar

44. Leibowitz U, Antonovsky A, Medalie JM, Smith HA, Halpern L, Alter M. Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation. J Neurol Neurosurg Psychiatry 1966;29:60–8.10.1136/jnnp.29.1.60 Search in Google Scholar PubMed PubMed Central

45. Krause I, Anaya JM, Fraser A, Barzilai O, Ram M, Abad V, et al. Anti-infectious antibodies and autoimmune-associated autoantibodies in patients with type I diabetes mellitus and their close family members. Ann N Y Acad Sci 2009;1173:633–9.10.1111/j.1749-6632.2009.04619.x Search in Google Scholar PubMed

46. Ram M, Anaya JM, Barzilai O, Izhaky D, Porat Katz BS, Blank M, et al. The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders. Autoimmun Rev 2008;7:621–5.10.1016/j.autrev.2008.06.008 Search in Google Scholar PubMed

47. Ohkusa T, Nomura T, Sato N. The role of bacterial infection in the pathogenesis of inflammatory bowel disease. Intern Med 2004;43:534–9.10.2169/internalmedicine.43.534 Search in Google Scholar PubMed

48. Vare PO, Heikius B, Silvennoinen JA, Karttunen R, Niemela SE, Lehtola JK, et al. Seroprevalence of Helicobacter pylori infection in inflammatory bowel disease: is Helicobacter pylori infection a protective factor? Scand J Gastroenterol 2001;36:1295–300.10.1080/003655201317097155 Search in Google Scholar PubMed

49. Sonnenberg A, Genta RM. Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease. Aliment Pharmacol Ther 2012;35:469–76.10.1111/j.1365-2036.2011.04969.x Search in Google Scholar PubMed

50. Kelly D, Conway S, Aminov R. Commensal gut bacteria: mechanisms of immune modulation. Trends Immunol 2005;26:326–33.10.1016/j.it.2005.04.008 Search in Google Scholar PubMed

51. Shapira Y, Agmon-Levin N, Shoenfeld Y. Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 2010;34:J168–77.10.1016/j.jaut.2009.11.018 Search in Google Scholar PubMed

52. Gavalas E, Kountouras J, Deretzi G, Boziki M, Grigoriadis N, Zavos C, et al. Helicobacter pylori and multiple sclerosis. J Neuroimmunol 2007;188:187–9; author reply 90.10.1016/j.jneuroim.2007.06.007 Search in Google Scholar PubMed

53. Li W, Minohara M, Su JJ, Matsuoka T, Osoegawa M, Ishizu T, et al. Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population. J Neuroimmunol 2007;184:227–31.10.1016/j.jneuroim.2006.12.010 Search in Google Scholar PubMed

54. Sawalha AH, Schmid WR, Binder SR, Bacino DK, Harley JB. Association between systemic lupus erythematosus and Helicobacter pylori seronegativity. J Rheumatol 2004;31:1546–50.Search in Google Scholar